Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OCS

+ Watchlist+ Portfolio

Oculis Holding AG

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$7.39
52-Week Range
$6.78 – $34.48
Market Cap
$414.52M
P/E (TTM)
—
EPS (TTM)
-1.69
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.79
PEG Ratio
—
Return on Equity
-47.49%
Return on Assets
-27.98%
Gross Margin
0.00%
Operating Margin
-9558.91%
Profit Margin
0.00%
Current Ratio
10.41
Debt/Equity
0.01
Total Debt
$2.79M
Free Cash Flow
—
Revenue Growth
-97.10%
Earnings Growth
—
Enterprise Value
$241.71M

Market Snapshot

About

Oculis Holding AG is an ophthalmic biopharmaceutical company developing innovative treatments for eye diseases including diabetic macular edema and dry eye disease.